...
ModraDoc006/Ritonavir Offers Promising Therapeutic Option for mCRPC
11 February 2021 ModraDoc006/Ritonavir Offers Promising Therapeutic Option for mCRPC, Convenient Approach Amid COVID-19 Pandemic Article published in ...
Modra Pharmaceuticals Announces First Patients Treated in Phase IIb Metastatic Prostate Cancer Trial
14 august 2019 –Study will test efficacy and tolerability of novel docetaxel-based oral chemotherapeutic ModraDoc006/r– Amsterdam A...